Expanding the Promise of Immunotherapy

Leveraging elite immune responses to develop novel cancer immunotherapies

 

The Right People in the Right Place at the Right Time

Making advancements in immuno-oncology through strategic partnerships

 

News

October 10, 2016
OncoResponse Secures $7M in Supplemental Series A Funding

May 26, 2016
OncoResponse Secures Investment from Baxalta